News & Media

Press releases & statements

Apply filter
Oct 11, 2023
COVID-19,Seasonal influenza

Novavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023

Read full article
Download
May 9, 2023
COVID-19,Seasonal influenza

Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses

Read full article
Download
Apr 4, 2023
COVID-19,Seasonal influenza

Novavax Grows Presence at World Vaccine Congress 2023 and 33rd European Congress of Clinical Microbiology & Infectious Diseases

Read full article
Download
Dec 30, 2022
COVID-19,Seasonal influenza

Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates

Read full article
Download
Oct 20, 2022
COVID-19,Seasonal influenza

Novavax Showcases Data from Expanding Vaccine Portfolio at IDWeek 2022

Read full article
Download
Oct 13, 2022
COVID-19,Seasonal influenza

Novavax COVID-19-Influenza Combination Vaccine Candidate Induced Antibody and T-Cell Responses Against SARS-CoV-2 and Homologous and Heterologous Influenza Strains

Read full article
Download
Oct 10, 2022
COVID-19,Seasonal influenza

Novavax to Share New Data from Growing Vaccine Portfolio at World Vaccine Congress Europe 2022

Read full article
Download
Jun 17, 2022
Statement
COVID-19,Seasonal influenza

Novavax to Showcase Innovative Vaccine Data at Communicable Diseases & Immunisation Conference 2022

Read full article
Download
Oct 15, 2021
COVID-19,Seasonal influenza

Novavax to Participate in World Vaccine Congress Europe

Read full article
Download
Sep 23, 2021
Seasonal influenza

Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases

Read full article
Download
Showper page